Thermo Fisher Scientific Inc. (TMO) News
Filter TMO News Items
TMO News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
TMO News Highlights
- TMO's 30 day story count now stands at 17.
- Over the past 21 days, the trend for TMO's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about TMO are TOP, DX and AB.
Latest TMO News From Around the Web
Below are the latest news stories about THERMO FISHER SCIENTIFIC INC that investors may wish to consider to help them evaluate TMO as an investment opportunity.
Thermo Fisher Scientific (TMO) Laps the Stock Market: Here's WhyIn the closing of the recent trading day, Thermo Fisher Scientific (TMO) stood at $531.65, denoting a +0.37% change from the preceding trading day. |
HSBC Sees Opportunity in These 2 Biopharma Giants Ahead of the 2024 ElectionsThe silly season is upon us. Not the holidays – but the election. We’re less than 11 months out from the Presidential vote, and the first primary, the Iowa GOP caucus, is less than 30 days away. Election years are the ‘known unknown’ of the US economy. We know they’re coming, we know the results can change everything, we know that every economic sector will react differently – but we never truly know how those changes will shake out. This cyclical truth of politics and financial markets informs |
Thermo Fisher (TMO) Unveils CorEvitas Pharmacovigilance PlatformThermo Fisher (TMO) introduces the CorEvitas pharmacovigilance platform for clinical research registries. |
Thermo Fisher Scientific's (NYSE:TMO) investors will be pleased with their impressive 139% return over the last five yearsThe most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if... |
Thermo Fisher's (TMO) PPD Business Backs BARDA's Clinical TrialThermo Fisher's (TMO) PPD clinical research business is selected by BARDA to support the Phase II platform clinical trial to treat ARDS. |
Why Thermo Fisher Scientific (TMO) Dipped More Than Broader Market TodayThermo Fisher Scientific (TMO) reachead $519.43 at the closing of the latest trading day, reflecting a -1.65% change compared to its last close. |
Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?Let's talk about the popular Thermo Fisher Scientific Inc. ( NYSE:TMO ). The company's shares received a lot of... |
Thermo Fisher (TMO) to Allocate IFA Testing Kits With New PactThermo Fisher (TMO) will continue to meet the evolving needs of laboratories and healthcare professionals by expanding its immunology product portfolio of EliA autoimmune diagnostics. |
Are Strong Financial Prospects The Force That Is Driving The Momentum In Thermo Fisher Scientific Inc.'s NYSE:TMO) Stock?Thermo Fisher Scientific (NYSE:TMO) has had a great run on the share market with its stock up by a significant 9.6... |
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of OlinkWALTHAM, Mass., December 15, 2023--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the "Buyer"), has extended the expiration time of the offering period of its previously announced tender offer (the "Offer") to acquire all of the outstanding common shares ("Shares") and all of the outstanding American Depositary Shares, each representing one Share ("ADSs" and, together with the Sha |